Stock Comparison
CORT vs VRTX
Corcept Therapeutics Incorporated and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$11.58B
$123.94B
P/E (TTM)
238.1
28.5
Forward P/E
54.4
25.7
Price/Sales
13.9
9.9
Price/Book
16.4
6.1
EV/EBITDA
1,274.7
23.2
Dividend Yield
—
—
Profitability
Net Margin
6.61%
35.40%
Operating Margin
0.77%
38.97%
Return on Equity
8.23%
23.50%
Return on Assets
0.47%
11.90%
Growth (YoY)
Revenue Growth
31.70%
12.50%
Earnings Growth
24.10%
8.00%
Price & Risk
Beta
0.5
0.3
52-Week High
$118.32
$529.65
52-Week Low
$32.15
$376.62
Analyst Target
$135.25
$559.28
Compare CORT and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.